BNET Industries

Last Fiscal Year Sales:$1.4B
- Private
- US
Dow Jones Description
Contact Lenses & Vision Care Products Mfr
Chief Executive Officer
Andrea SaiaNumber of Employees 5,479
Contact Information
11460 Johns Creek Pkwy
Duluth, Georgia 30097-1518
(678) 415-3937
Peer Companies
NAICS Code Surgical Appliance and Supplies Manufacturing: 339113
News & Analysis
Filter by
ciba vision corp. and qlt inc. - All News and Analysis
QLT announces Visudyne(TM) sales for third quarter Company confident of continued strong growth in sales.
VANCOUVER, Oct 11, 2000 Following today's release of third quarter sales by Novartis AG (NYSE: NVS), QLT Inc. (NASDAQ: QLTI; TSE: QLT) reported global VisudyneTM therapy sales of U.S. $31 million (CDN $46.5 million or 53 million Swiss Francs) for the quarter ended September...
QLT and Ciba Vision seek to expand the indication for Visudyne.
ATLANTA, and VANCOUVER, Aug 14, 2000 CIBA Vision Corporation, the eye care unit of Novartis AG (NYSE:NVS), and QLT Inc. (NASDAQ:QLTI; TSE:QLT) today announced the filing of a supplemental new drug application sNDA for VisudyneTM verteporfin for injection therapy with the United States Food...
NOVARTIS: Ciba Vision and QLT Phototherapeutics an announce FDA Committee review for Visudyne Therapy.
M2 PRESSWIRE-7 October 1999-NOVARTIS: Ciba Vision and QLT Phototherapeutics announce FDA Advisory Committee review for Visudyne Therapy C1994-99 M2 COMMUNICATIONS LTD RDATE:061099 ATLANTA and VANCOUVER -- CIBA Vision Corporation, the eye care unit of Novartis AG, and QLT PhotoTherapeutics Inc. announced...
CIBA VISION: Ciba Vision and QLT announce regulatory su submission.
M2 PRESSWIRE-17 August 1999-CIBA VISION: Ciba Vision and QLT announce regulatory submission C1994-99 M2 COMMUNICATIONS LTD RDATE:160899 * Seeking approval of Visudyne therapy for wet Amd in the United States Atlanta, Georgia and Vancouver, Canada -- CIBA Vision Corporation,...
NOVARTIS: Novartis' eye-care unit CIBA Vision and QLT announce positive results for Visudyne therapy.
M2 PRESSWIRE-6 January 1999-NOVARTIS: Novartis' eye-care unit CIBA Vision and QLT announce positive results for Visudyne verteporfin therapy for wet age-related macular degeneration C1994-99 M2 COMMUNICATIONS LTD RDATE:050199 Atlanta, USA/Vancouver, Canada -- CIBA Vision Corporation, the eye-care unit of Novartis,...
QLT PhotoTherapeutics - Light-Activated Drug May Offer New Treatment for Leading Cause of Blindness Among Elderly
FT. LAUDERDALE, Fla.--BUSINESS WIRE--April 23, 1996-- QLT PHOTOTHERAPEUTICS (NASDAQ: QLTIF, TSE: QLT ) New clinical research indicates a light- activated drug being jointly developed by QLT PhotoTherapeutics Inc. QLT and CIBA Vision Ophthalmics may offer a potential treatment for Age-related Macular Degeneration, the leading cause of blindness in persons over...
Ciba Vision And Qlt Begin U.S. Clinical Trial Of Bpd For Eye Disease
BOSTON, MA--BUSINESS WIRE--MAY 2, 1995--QUADRA LOGIC(TSE: QLT NASDAQ: QLTIF) Researchers at the Massachusetts Eye and Ear Infirmary and Harvard Medical School have commenced a Phase I safety and proof- of-concept clinical study involving the use of the light-activated drug, Benzoporphyrin derivative BPD, as a potential treatment for Age-related Macular Degeneration....
Ciba-Vision and QLT begin U.S. clinical trial of BPD for eye disease
BOSTON--BUSINESS WIRE--May 2, 1995--Researchers at the Massachusetts Eye and Ear Infirmary and Harvard Medical School have commenced a Phase I safety and proof- of-concept clinical study involving the use of the light-activated drug, Benzoporphyrin derivative BPD, as a potential treatment for Age-related Macular Degeneration. The clinical study is being...
Qlt Acquires Exclusive License To Ciba's Photodynamic Therapy Drug
VANCOUVER, BC--BUSINESS WIRE--April 4, 1995-- Quadra Logic Technologies Inc. QLT and Ciba-Geigy Limited Ciba, announced today that QLT has acquired an exclusive worldwide license to develop and market Ciba's Photodynamic Therapy PDT drug, Zinc Phthalocyanine ZnPc, additional photosensitive compounds and complementary technology for PDT.This agreement supercedes the Letter of Intent...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Andrea Saia | Chief Executive Officer |
| Karen Gough | President, Americas |
| John McKenna | Chief Financial Officer |
| Ray Greer | Chief Information Officer |
| Ricky Abbas | Chief Strategy Officer |
| Erich Bauman | Vice President, Global Specialty Lens Business |
| Mike Dilworth | Vice President, Manufacturing |
| Mike Grayson | Vice President, Manufacturing |
| Rick Weisbarth | Vice President, Global Head Professional Development & Partnerships |
| Peter Bergenske | Director of Clinical Research and Development |
| John P Beaumont | Engineering Manager |
| Carolee R Boyd | Clinical Investigator |
| Dave Holland | |
| Hidekazu Hayakawa | Head of CIBA Vision Japan |
| Jeffery S Hackleman | Clinical Investigator |
| Jerry Becker | |
| Joe Doner | Head, Global Supply Chain |
| John Rex | Finance Officer |
| Martin Filippides | Global Head of Human Resources |
| R. Scott Meece | General Counsel |
| Susanne Kohout | Head of Europe, Middle East and Africa (EMEA) regions |
| Tariq Aziz | Global Head of Corporate Development |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Chief Executive Officer | Current |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | President, Americas | Current |
John McKenna is CIBA Vision's Chief Financial Officer. Mr. McKenna is a graduate of the DeGroote School of Business's Commerce program at McMaster University. He also holds both CGA and CMA accounting designations.
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Chief Financial Officer | Current |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Chief Information Officer | Current |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Chief Strategy Officer | Current |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Vice President, Global Specialty Lens Business | Current |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Vice President, Manufacturing | Current |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Vice President, Manufacturing | Current |
Dr. Rick Weisbarth is currently the president of the American Academy of Optometry and serves as vice president, Global Head Professional Development & Partnerships for CIBA VISION Corporation, the eye care division of Novartis. Dr. Weisbarth received his O.D. degree from the Ohio State University College of Optometry. Following graduation, he served in the Contact Lens Practice Residency Program at the University of Alabama in Birmingham School of Optometry. He has conducted a private optometric practice and held several different positions in clinical research and professional services for CIBA VISION Corporation in the United States and Switzerland. Dr. Weisbarth has published and lectured internationally on a variety of contact lens and lens care related topics. He is a fellow of the American Academy of Optometry and a diplomat in its Cornea and Contact Lens Section. In 1996, Dr. Weisbarth was elected to the Academy's Executive Council. In 2004, Dr. Weisbarth was inducted into the National Academies of Practice as a distinguished practitioner in optometry.
| Organization | Position | Status |
|---|---|---|
| American Academy of Optometry | President | Current |
| CIBA Vision Corporation | Vice President, Global Head Professional Development & Partnerships | Current |
| Ciba Vision Gmbh | Current | |
| American Academy of Optometry | Board of Directors | Current |
| Solohealth, Inc. | Board of Directors | Current |
| American Academy of Optometry | Fellow | Current |
| The Ohio State University College of Optometry | Degree | Former |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Director of Clinical Research and Development | Current |
| American Academy of Optometry | Board of Directors | Current |
| Pacific University College of Optometry | Associate Professor | Former |
| University of Wisconsin | Bachelor's Degree | Former |
John Beaumont is a professor at the Plastics Engineering Technology program at Penn State Erie, The Behrend College. John has co-authored several books published by Hanser Gardner Publications, and owns several patents in the industry. Beaumont is also the founder/director of the Penn State Erie Plastics CAE Center and was the chairperson for the Injection Molding Division of SPE from 1998-1999. Prior to coming to Penn State, John has years of industrial experience in mold design and as Technical Manager for Moldflow North America.
| Organization | Position | Status |
|---|---|---|
| Beaumont Technologies Inc. | President | Current |
| Penn State Erie Plastics Cae Center | Founder | Current |
| Penn State Erie Plastics Cae Center | Director of the Plastics Cae Center and Assistant Professor of Engineering | Current |
| Penn State Erie Plastics Cae Center | Assistant Professor | Current |
| Penn State | Cae Center | Former |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Clinical Investigator | Current |
| DRS. Kline & Boyd | Current | |
| Hartwick College | Former |
Array
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Current | |
| Princeton University | Ba In Politics | Former |
| Novartis Ophthalmics, Inc | Vice President of Marketing | Former |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Head of CIBA Vision Japan | Current |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Clinical Investigator | Current |
| Mario Outten | Current | |
| Heritage Vision Center | Current | |
| The Ohio State University College of Optometry | Doctorate | Former |
| Purdue University | BS In Neurobiology | Former |
Dr. Becker is a graduate of University of Houston. He has been in practice for 25 years. He is a member of the American Optometric Association and Missouri Optometric Association. He is currently working with CIBA Vision Corporation on a study involving patient satisfaction with their new Focus progressive bifocal contact lenses. Dr. Becker specializes in fitting all types of contact lenses.
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Current | |
| Midwest Eye Associates | Current | |
| The University of Houston | Former |
Joe Doner is Head of CIBA Vision's Global Supply Chain. He has a bachelor's degree in Mechanical Engineering from Rose Hulman Institute of Technology in Terre Haute, Indiana and has taken graduate courses at Southeastern Missouri University.
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Head, Global Supply Chain | Current |
| Rose-Hulman Institute of Technology | Bachelor's Degree In Mechanical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Finance Officer | Current |
Mr. Filippides joined CIBA Vision in 2005 from Quintiles Transnational where he was Vice President of Human Resources - Americas, as well as the Global Human Resources head for the Late Phase clinical development business. Based in Raleigh, North Carolina, Quintiles Transnational provides the full spectrum of product development and commercialization activities, from early compound development, laboratory services and regulatory submission through sales and marketing to the pharmaceutical, biotechnology and healthcare industries.
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Global Head of Human Resources | Current |
| Ciba Vision Gmbh | Current | |
| Quintiles Transnational Corp. | Vice President of Human Resources | Former |
| The Well, LLC | Former |
Scott Meece is Worldwide General Counsel for CIBA Vision Corporation. He is also head of the company's global Scientific Affairs, and the global Health, Safety & Environment group. Mr. Meece joined Novartis Corporation (formerly Ciba-Geigy) as CIBA Vision Patent Counsel in October 1993. Prior to that he was a Patent Attorney at Alza Corporation and Phillips Petroleum Company. Mr. Meece also spent seven years at Ford Motor Company as Research/Prototype Engineer and Senior Process Engineer. Mr. Meece is a graduate of the University of Illinois with a bachelor's of science degree in Chemical Engineering and a bachelor's of science with distinction in Mathematics. He received his master's in Chemical Engineering from Wayne State University and his juris doctor from The University of Tulsa College of Law. Mr. Meece is licensed to practice law in Georgia, California and Oklahoma, as well as before the U.S. Patent and Trademark Office. Mr. Meece is the Chairman for the Atlanta Area Council of The American Diabetes Association. He was on the board of directors for the Greater North Fulton Chamber of Commerce and was a cubmaster for the Boy Scouts of America.
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | General Counsel | Current |
| ALZA Corporation | Attorney | Former |
| Greater North Fulton Chamber of Commerce | Board of Directors | Former |
| University of Tulsa College of Law | Juris Doctor | Former |
| Wayne State University | Master's In Chemical Engineering | Former |
| University of Illinois | Bachelor's of Science Degree In Chemical Engineer | Former |
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Head of Europe, Middle East and Africa (EMEA) regions | Current |
Tariq F. Aziz, is Global Head of Corporate Development. He has a bachelor's of Science degree from NED University in Pakistan. He also earned a master's of Science from North Carolina State University and an MBA from Carnegie Mellon University, Pittsburgh, PA.
| Organization | Position | Status |
|---|---|---|
| CIBA Vision Corporation | Global Head of Corporate Development | Current |
| Carnegie Mellon University | Mba | Former |
| North Carolina State University | Master's of Science | Former |
Industry Transcripts by Seeking Alpha
-
Cantel Medical Corp. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 09, 2009about CMN
-
The Cooper Companies, Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about COO
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
